Search results
Results from the WOW.Com Content Network
The Electronic Medicines Compendium is a provider of information on medicines, produced by Datapharm. It lists summaries of product characteristics and patient information leaflets. [1][2]
A package insert is a document included in the package of a medication that provides information about that drug and its use. For prescription medications, the insert is technical, providing information for medical professionals about how to prescribe the drug. Package inserts for prescription drugs often include a separate document called a ...
The Summary of Product Characteristics provided in the electronic Medicines Compendium [eMC [16]] further lists common and uncommon adverse reactions that have been reported for Lemtrada, which include serious opportunistic nocardial infections and cytomegalovirus syndrome. [17] [18] [19]
Zonisamide is approved in the United States, [2] [12] and United Kingdom [13] for adjunctive treatment of partial seizures in adults and Japan for both adjunctive and monotherapy for partial seizures (simple, complex, secondarily generalized), generalized (tonic, tonic-clonic (grand mal), and atypical absence) and combined seizures. [14]
Eno was advertised heavily, as all patent medicines were at that time. [5] In 1883 it was advertised as a cure for cholera [9] and in 1892 for "keeping blood pure and free from disease", prevention of diarrhea, and many other conditions. [10] By 1928 the company had factories in England, Canada, France, Germany, Spain, and the US; that year the ...
Cabergoline. Cabergoline, sold under the brand name Dostinex among others, is a dopaminergic medication used in the treatment of high prolactin levels, prolactinomas, Parkinson's disease, and for other indications. [2] It is taken by mouth. Cabergoline is an ergot derivative and a potent dopamine D 2 receptor agonist.
Eslicarbazepine acetate (ESL), sold under the brand names Aptiom and Zebinix among others, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy for partial-onset seizures epilepsy. [6][4][3] Similarly to oxcarbazepine, ESL behaves as a prodrug to (S)- (+)- licarbazepine. [7]
The linker group that makes emtansine is shown in blue at right, bound to the amino group (HN–) of a lysine residue in the trastuzumab molecule (–mab). Trastuzumab emtansine is an antibody-drug conjugate (ADC), a combination between a monoclonal antibody and a small-molecule drug. Each molecule of trastuzumab emtansine consists of a single ...